Total Payments
$917.41
2024 Payments
$197.04
Companies
18
Transactions
38
Medicare Patients
1,422
Medicare Billing
$44,037
Payment Breakdown by Category
Food & Beverage$835.90 (91.1%)
Education$81.51 (8.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $835.90 | 32 | 91.1% |
| Education | $81.51 | 6 | 8.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $281.31 | 8 | $0 (2021) |
| Lexicon Pharmaceuticals, Inc. | $119.04 | 1 | $0 (2024) |
| PFIZER INC. | $86.84 | 6 | $0 (2023) |
| AMAG Pharmaceuticals, Inc. | $65.16 | 5 | $0 (2018) |
| INTUITIVE SURGICAL, INC. | $64.76 | 1 | $0 (2024) |
| Agile Therapeutics, Inc. | $50.38 | 3 | $0 (2021) |
| HOLOGIC INC | $37.46 | 2 | $0 (2017) |
| Bayer Healthcare Pharmaceuticals Inc. | $35.82 | 2 | $0 (2023) |
| Boston Scientific Corporation | $25.36 | 1 | $0 (2019) |
| Merck Sharp & Dohme LLC | $21.18 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $197.04 | 3 | Lexicon Pharmaceuticals, Inc. ($119.04) |
| 2023 | $49.78 | 3 | Bayer Healthcare Pharmaceuticals Inc. ($35.82) |
| 2022 | $100.67 | 6 | PFIZER INC. ($28.63) |
| 2021 | $161.10 | 5 | AbbVie Inc. ($94.37) |
| 2020 | $36.13 | 2 | AbbVie Inc. ($36.13) |
| 2019 | $75.64 | 4 | Boston Scientific Corporation ($25.36) |
| 2018 | $180.80 | 8 | AbbVie, Inc. ($131.59) |
| 2017 | $116.25 | 7 | HOLOGIC INC ($37.46) |
All Payment Transactions
38 individual payment records from CMS Open Payments — Page 2 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/13/2018 | AbbVie, Inc. | Orilissa (Drug) | Food and Beverage | In-kind items and services | $3.24 | General |
| Category: Endocrinology | ||||||
| 08/02/2018 | AbbVie, Inc. | Orilissa (Drug) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: Endocrinology | ||||||
| 06/04/2018 | PFIZER INC. | PREMARIN (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: WOMENS HEALTH | ||||||
| 05/17/2018 | AMAG Pharmaceuticals, Inc. | INTRAROSA (Drug) | Education | In-kind items and services | $11.39 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 05/14/2018 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $7.38 | General |
| 04/05/2018 | AMAG Pharmaceuticals, Inc. | INTRAROSA (Drug) | Education | In-kind items and services | $11.51 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 12/07/2017 | PFIZER INC. | PREMARIN ORALS (Drug), PVC, ESTRING | Food and Beverage | In-kind items and services | $11.87 | General |
| Category: WOMENS HEALTH | ||||||
| 10/05/2017 | AMAG Pharmaceuticals, Inc. | INTRAROSA (Drug) | Education | In-kind items and services | $16.02 | General |
| Category: INTRAROSA | ||||||
| 09/18/2017 | AMAG Pharmaceuticals, Inc. | INTRAROSA (Drug) | Education | In-kind items and services | $13.38 | General |
| Category: INTRAROSA | ||||||
| 09/07/2017 | PFIZER INC. | PREMARIN ORALS (Drug), PVC, ESTRING | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: WOMENS HEALTH | ||||||
| 06/29/2017 | HOLOGIC INC | Novasure (Device) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: Surgical | ||||||
| 02/23/2017 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: Urology | ||||||
| 02/16/2017 | HOLOGIC INC | Novasure (Device) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Surgical | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 218 | 227 | $22,891 | $9,283 |
| 2022 | 6 | 335 | 344 | $25,909 | $10,934 |
| 2021 | 5 | 618 | 634 | $35,160 | $16,340 |
| 2020 | 5 | 251 | 269 | $18,075 | $7,481 |
Total Patients
1,422
Total Services
1,474
Medicare Billing
$44,037
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 160 | 160 | $16,000 | $5,950 | 37.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 31 | 35 | $4,375 | $2,193 | 50.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 16 | 21 | $1,680 | $690.82 | 41.1% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 11 | 11 | $836.00 | $448.58 | 53.7% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 137 | 137 | $12,120 | $5,213 | 43.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 35 | 43 | $6,175 | $2,131 | 34.5% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 51 | 51 | $4,769 | $2,128 | 44.6% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2022 | 45 | 45 | $1,125 | $810.63 | 72.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 13 | 14 | $1,180 | $463.06 | 39.2% |
| 81002 | Urinalysis, manual test | Office | 2022 | 54 | 54 | $540.00 | $187.08 | 34.6% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 156 | 156 | $12,480 | $5,959 | 47.8% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 95 | 95 | $9,025 | $3,990 | 44.2% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2021 | 179 | 179 | $4,475 | $3,231 | 72.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 36 | 51 | $7,650 | $2,628 | 34.3% |
| 81002 | Urinalysis, manual test | Office | 2021 | 152 | 153 | $1,530 | $532.44 | 34.8% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 63 | 63 | $5,040 | $2,463 | 48.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 29 | 47 | $7,050 | $1,941 | 27.5% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2020 | 39 | 39 | $3,705 | $1,618 | 43.7% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2020 | 72 | 72 | $1,800 | $1,293 | 71.8% |
| 81002 | Urinalysis, manual test | Office | 2020 | 48 | 48 | $480.00 | $165.78 | 34.5% |
About Dr. Michele Jacobson, D.O
Dr. Michele Jacobson, D.O is a Obstetrics & Gynecology healthcare provider based in Latrobe, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1235115221.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michele Jacobson, D.O has received a total of $917.41 in payments from pharmaceutical and medical device companies, with $197.04 received in 2024. These payments were reported across 38 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($835.90).
As a Medicare-enrolled provider, Jacobson has provided services to 1,422 Medicare beneficiaries, totaling 1,474 services with total Medicare billing of $44,037. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Location Latrobe, PA
- Active Since 12/21/2005
- Last Updated 09/10/2025
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1235115221
Products in Payments
- Inpefa (Drug) $119.04
- Mavyret (Drug) $97.69
- INTRAROSA (Drug) $65.16
- Da Vinci Surgical System (Device) $64.76
- Twirla (Drug) $50.38
- Orilissa (Drug) $45.74
- PREMARIN (Drug) $43.87
- Novasure (Device) $37.46
- Mirena (Drug) $35.82
- PREMARIN ORALS (Drug) $30.80
- MYFEMBREE (Drug) $28.52
- EMBLEM (Device) $25.36
- GARDASIL 9 (Biological) $21.18
- ORILISSA (Drug) $21.16
- VYVANSE (Drug) $20.02
- Myrbetriq (Drug) $18.59
- GEMTESA (Drug) $18.49
- SLYND (Drug) $18.42
- LO LOESTRIN FE (Drug) $14.97
- ANNOVERA (Drug) $13.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Latrobe
Dr. Robert Donley, D.o, D.O
Obstetrics & Gynecology — Payments: $6,632
Obstetrics & Gynecology $6,632
Dr. Greg Whorral, M.d, M.D
Obstetrics & Gynecology — Payments: $2,760
Obstetrics & Gynecology $2,760
Stacey Carlitz
Obstetrics & Gynecology — Payments: $495.72
Obstetrics & Gynecology $495.72
Dr. Francis Defabo, Md, MD
Obstetrics & Gynecology — Payments: $48.75
Obstetrics & Gynecology $48.75